» Articles » PMID: 34347282

A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris

Overview
Specialty Dermatology
Date 2021 Aug 4
PMID 34347282
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching, burning or tenderness. Due to scarring, hair loss is typically permanent. The main goals of treatment are reducing symptoms and preventing disease progression and further hair loss. Currently, the literature has limited evidence on treatments for this difficult condition, and most available evidence is from case reports and case series. Furthermore, the evidence shows a varied response to therapy, with frequent reports of poor response. This article reviews the diagnosis of this rare disease, summarize the currently available treatments, and provide insights and practices from alopecia experts.

Citing Articles

Efficacy and Safety of Tofacitinib in Lichen Planopilaris: A Retrospective Series of 74 Patients.

Goodarzi M, Dadkhahfar S, Yahyaei F, Razzaghi Z, Moravvej H Arch Iran Med. 2025; 28(1):24-28.

PMID: 40001326 PMC: 11862399. DOI: 10.34172/aim.33237.


The role of skin microbiota in lichen planus from a Mendelian randomization perspective.

Hu S, Huang X, Dong J, Che Y, Guo J Arch Dermatol Res. 2025; 317(1):245.

PMID: 39812683 DOI: 10.1007/s00403-024-03677-8.


Beard Lichen Planopilaris: Report of Two Cases.

Ali S, Belcadi J, Sassine F, Ammar N, Znati K, Meziane M Dermatol Pract Concept. 2024; 14(4).

PMID: 39652922 PMC: 11619928. DOI: 10.5826/dpc.1404a240.


Lichen planus-the role of age and gender in clinical appearance and treatment : A narrative review.

Wollina U, Koch A, Fida M, Chiriac A, Hasan A, Abdelmaksoud A Wien Med Wochenschr. 2024; .

PMID: 39531121 DOI: 10.1007/s10354-024-01057-5.


Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris.

Otlewska-Szpotowicz A, Baran W, Wozniak Z, Szepietowski J, Batycka-Baran A Postepy Dermatol Alergol. 2024; 41(4):364-371.

PMID: 39290897 PMC: 11404093. DOI: 10.5114/ada.2024.142179.


References
1.
Kang H, Alzolibani A, Otberg N, Shapiro J . Lichen planopilaris. Dermatol Ther. 2008; 21(4):249-56. DOI: 10.1111/j.1529-8019.2008.00206.x. View

2.
Assouly P, Reygagne P . Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009; 28(1):3-10. DOI: 10.1016/j.sder.2008.12.006. View

3.
Errichetti E, Figini M, Croatto M, Stinco G . Therapeutic management of classic lichen planopilaris: a systematic review. Clin Cosmet Investig Dermatol. 2018; 11:91-102. PMC: 5833781. DOI: 10.2147/CCID.S137870. View

4.
Trager M, Lavian J, Lee E, Gary D, Jenkins F, Christiano A . Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in a New York City health care system. J Am Acad Dermatol. 2020; 84(4):1166-1169. DOI: 10.1016/j.jaad.2020.10.081. View

5.
Ochoa B, King Jr L, Price V . Lichen planopilaris: Annual incidence in four hair referral centers in the United States. J Am Acad Dermatol. 2008; 58(2):352-3. DOI: 10.1016/j.jaad.2007.11.007. View